Current Data

U.S. Cannabis Spot Index up 0.3% to $1,068 per pound.

The simple average (non-volume weighted) price increased $53 to $1,161 per pound, with 68% of transactions (one standard deviation) in the $389 to $1,932 per pound range. The average reported deal size increased to 2.9 pounds from 2.7 pounds last week. In grams, the Spot price was $2.36 and the simple average price was $2.56.

The relative frequency of trades for indoor flower increased week-over-week by 4%. The relative frequency of transactions involving greenhouse and outdoor product decreased by 1% and 3%, respectively. Greenhouse product’s share of the total reported weight moved nationwide contracted by 2% relative to last week. The relative volumes of warehouse and outdoor flower both increased by 1% each. National relative volumes one year ago at this time were observed at 53%, 29%, and 18%, for indoor, greenhouse, and outdoor product, respectively.  

The U.S. Spot Index ticked upward marginally this week, by $2, to settle at $1,068 per pound, recovering slightly from last week’s current annual low. Relative steadiness in the Spot Indices of California and Washington helped to offset declines in Colorado and Oregon, while rising rates in Nevada, Michigan, New Mexico, and Alaska, among others, ultimately pushed the national composite price up a bit. Last year at this time – a week ahead of 4/20 – the U.S. Spot Index slipped by 1.4%, from $1,386 to $1,367 per pound, although it must be noted that it had previously trended upward from mid-February through early April. This week’s national composite price is off by 22% year-over-year, maintaining the overall rate of decline observed in annual average prices from 2017 to 2018, which was 23%.

The national volume-weighted price for flower to be sold in adult-use markets rose slightly this week on significant increases in the Spot Indices of Nevada and Alaska, as well as a modest uptick in Washington’s composite price. Rising prices for medical product in Illinois, Michigan, and New Mexico, as well as a couple other smaller markets, were primarily responsible for pushing up the national rate for flower to be sold to patients.